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3T3-L1 preadipocytes ectopically expressing the mammalian RNA-binding protein Hel-N1 expressed up to
10-fold more glucose transporter (GLUT1) protein and exhibited elevated rates of basal glucose uptake. Hel-N1
is a member of the ELAV-like family of proteins associated with the induction and maintenance of differen-
tiation in various species. ELAV proteins are known to bind in vitro to short stretches of uridylates in the 3￿
untranslated regions (3￿UTRs) of unstable mRNAs encoding growth-regulatory proteins involved in transcrip-
tion and signal transduction. GLUT1 mRNA also contains a large 3￿UTR with a U-rich region that binds
specifically to Hel-N1 in vitro. Analysis of the altered GLUT1 expression at the translational and posttran-
scriptional levels suggested a mechanism involving both mRNA stabilization and accelerated formation of
translation initiation complexes. These findings are consistent with the hypothesis that the Hel-N1 family of
proteins modulate gene expression at the level of mRNA in the cytoplasm.
Interaction of RNA-binding proteins with cis elements in
mRNAs is believed to be involved in regulation of their sta-
bility and translational efficiency (reviewed in reference 32).
The regulated stability of transferrin, granulocyte-macrophage
colony-stimulating factor, and histone mRNAs has been
shown, at least in part, to be controlled by the binding of
specific proteins to consensus sequences in the 3￿ untranslated
region (3￿UTR) of these messages (3, 37, 41). Studies of to-
bacco mosaic virus, the Drosophila melanogaster developmen-
tal gene hunchback, human cytokine, and 15-lipoxygenase
mRNAs have demonstrated that the 3￿UTR also contains in-
formation capable of regulating translational efficiency which
may be mediated by RNA-binding proteins (13, 25, 35, 36). A
major class of RNA-binding proteins which possess an 80-
amino-acid consensus element, termed the RNA recognition
motif (RRM) (39), which forms the core of a functional RNA-
binding domain has been identified.
Hel-N1 (human embryonic lethal abnormal vision [ELAV]-
like neuronal protein 1), a mammalian homolog of Drosophila
ELAV, is an mRNA-binding protein of the RRM family (15,
16, 27). Recent studies on Hel-N1, and the alternative form,
Hel-N2 (lacking a 13-amino-acid segment between RRM2 and
RRM3), in human medulloblastoma cells and embryonic car-
cinoma P19 cells have indicated that it plays a role in mRNA
metabolism (15). These proteins are bound to poly(A)￿
mRNA in granular RNP structures, and their expression is
upregulated during neuronal cell differentiation of P19 cells
(15). Likewise, hNT2 cells when induced to differentiate by
retinoic acid exhibited a marked increase in the expression of
human ELAV-like proteins which colocalized with mRNPs
associated with polysomes (1). Hence, data from both of these
studies support an important role for mammalian ELAV-like
proteins in the processes of cell growth and differentiation.
Interestingly, members of the ELAV family have been
shown to bind the AU-rich regions of the 3￿UTRs in cytokine
and proto-oncogene mRNAs (5, 14, 27). In vitro binding stud-
ies with Hel-N1 documented preferential binding to the
3￿UTRs of mRNAs which have short stretches of uridylate
residues; however, in vivo RNA targets of ELAV proteins have
not been identified (27). A combinatorial library representing
naturally derived 3￿UTRs was used to define brain mRNA
binding targets of Hel-N1 by in vitro iterative selection (14).
This approach allowed the identification of potential mRNA
binding targets which included transcripts encoding certain
tumor markers, transcription factors and growth regulatory
proteins.
Previous attempts to transfect various mammalian cell lines
such as B104, NIH 3T3, and COS with Hel-N1 resulted in
cessation of cellular proliferation and/or dramatic morpholog-
ical changes, precluding analysis of specific effects of Hel-N1
expression. In this study, we have examined the effect of ec-
topic expression of Hel-N1 on the expression of specific genes
in the 3T3-L1 cell system. As adipocytes, these cells express
two glucose transporters: GLUT1, a basal, growth-related
transporter; and GLUT4, the insulin-responsive glucose trans-
porter. Characterization of adipocytes expressing Hel-N1 dem-
onstrated an increased content of GLUT1 protein with no
alteration in the expression of GLUT4. Control of the increase
in GLUT1 content resides with translational (acceleration of
the formation of the translation initiation complexes) and post-
transcriptional (GLUT1 mRNA stability) mechanisms. Fur-
thermore, Hel-N1 was demonstrated to bind in vitro to the
AU-rich 3￿UTR of GLUT1 mRNA. We propose that Hel-N1
may compete with endogenous factors that normally regulate
mRNA translation or stability, giving rise to the secondary
effects on gene expression.
MATERIALS AND METHODS
Materials. Dulbecco’s modified Eagle’s medium was purchased from Gibco
Laboratories, Grand Island, N.Y. Bovine and fetal bovine sera were purchased
from HyClone, Logan, Utah. All radiolabeled compounds were obtained from
New England Nuclear, Boston, Mass., or ICN Biomedicals Inc., Irvine, Calif.
GLUT1 and GLUT4 antibodies were prepared and characterized as previously
described (22). The 3T3-L1 cells used in these experiments were obtained from
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Howard Green, Harvard University, Boston, Mass. Hybond-N and Hybond-NT
were obtained from Amersham, Arlington Heights, Ill. Protogel and Sequagel
were obtained from National Diagnostics. All other chemicals unless otherwise
specified were of molecular biology grade and purchased from Sigma, St. Louis,
Mo.
3T3-L1 cell culture. Murine 3T3-L1 preadipocytes were cultured, maintained,
and differentiated as previously described (42). Optimal differentiation was ob-
served by using a protocol that involved exposure of 3T3-L1 cells (day 0￿ 2 days
postconfluence) and transfectants to fetal bovine serum (10%), insulin (1 ￿g/ml),
1 ￿M dexamethasone (DEX), and 0.5 mM 3-isobutyl-1-methylxanthine (MIX).
Two days later, the culture medium was changed to medium lacking MIX and
DEX for maintenance of the cells in insulin. After 2 days, the concentration of
insulin was decreased to 250 ng/ml; 48 h later, insulin was omitted.
Determination of 2-deoxyglucose uptake. Assay of [3H]2-deoxyglucose uptake
was performed as we have described previously (38, 45). Results of such an assay
have been shown to approximate the actual hexose uptake rate in the 3T3-L1
adipocytes (11).
RNA isolation and analysis. Total RNA was isolated from the cells by extrac-
tion with guanidine isothiocyanate and centrifugation through 5.7 M cesium
chloride as described by Chirgwin et al. (4). Northern analysis was performed as
previously described (7, 42). Half-life determinations of the mRNA were per-
formed as described by Tebbey et al. (45).
Cell fractionation and GLUT1 and GLUT4 immunoblot analysis. Plasma and
intracellular membranes were separated and characterized as we have previously
described (42). Routinely, the microsomal phosphatase described by Klip and
Walker (24) was used as a marker for the intracellular membrane fraction.
Relative to the initial cell homogenate, a 28-fold purification with a 6.5% yield of
the phosphatase was obtained. As a marker for plasma membranes, ￿-glutamyl-
transferase was used (12). Recovery of this marker enzyme was approximately
10% with a purification of 60-fold. Immunoblot analysis was carried out as we
have described previously (42).
DNA probes. The cDNAs used in these studies were as follows: GLUT1, a
2.7-kb EcoRI fragment encoding the murine 3T3-L1 homolog of the HepG2/
brain glucose transporter (20); GLUT4, a 1.8-kb EcoRI fragment encoding the
3T3-L1 homolog of the adipose/muscle (insulin-responsive) glucose transporter
(20); and ￿-actin, a 1.9-kbHindIII fragment obtained from D. W. Cleveland, The
Johns Hopkins University School of Medicine, Baltimore, Md. (6).
Transfections. The cells were cotransfected at 50% confluence by the calcium
phosphate precipitation method with plasmids pSV2neo and pBC-Hel-N1 in a
1:10 ratio. Clones were selected on the basis of resistance to the aminoglycoside
G418 (400 ￿g/ml; active), pooled, passaged twice, and used in the described
experiments. Three individual transfections were performed, with a mean of
11 ￿ 3 clones pooled, the three derived cell lines exhibited the same phenotype,
and all experiments were performed with expansions of these original clones.
Construction of plasmids. The Hel-N1-expressing plasmid used for transfec-
tion of 3T3-L1 preadipocytes was derived from the pBC/CMV/IL2 vector (10).
The human interleukin-2 cDNA sequence of this vector was replaced with the
cDNA encoding a fusion protein consisting of a 12-amino-acid T7 phage gene 10
(g10) epitope tag (44) in frame with U1-70K cDNA (40). The U1-70K sequence
was removed by restriction digestion and replaced by a 1,656-nucleotide (nt)
Hel-N1 cDNA consisting of the protein coding region and the 3￿UTR. The
Hel-N1 sequence, inserted at the BamHI site downstream of the g10 tag, was
excised from the vector used for expression of Hel-N1 protein in Escherichia coli
(23).
Preparation and isolation of regions of the GLUT1 3￿UTR based on A￿U
content. The GLUT1 3￿UTR was divided into five regions based on A￿U
content. Each region was amplified by PCR techniques. The 5￿ primer contained
the sequence of the T7 promoter for the preparation of riboprobes for RNA gel
shift assays and immunoprecipitation experiments. The GLUT4 3￿UTR con-
struct is bp 1590 to 2500 of the insulin-responsive glucose transporter contained
within pBluescript (20). The plasmid was digested with restriction enzymes to
produce templates for T3 transcripts containing the complete 3￿UTR plus some
coding region (XhoI) and progressively shorter sequences which remove poten-
tial binding sites for Hel-N1. Digestion with HindIII eliminates a 21-nt U-rich
sequence (71% U, 81% A￿U) containing a maximum of five contiguous uridy-
lates. Digestion with TfiI eliminates (in addition to the above U-rich sequence)
the only AUUUA pentamer which occurs in the 3￿UTR of GLUT4.
In vitro analysis of RNA-protein interactions. RNA transcripts labeled with
[￿-32P]UTP were prepared as previously described (27). Immunoprecipitation of
Hel-N1-bound RNAs, using partially purified T7 g10 epitope-tagged protein (46)
and either anti-g10 or anti-Hel-N1 rabbit polyclonal antibodies (14), was per-
formed as described previously (27) except that the amount of protein A beads
per reaction was reduced to 1 mg. Electrophoretic gel mobility assays were
performed as previously described (27) except that [￿-32P]UTP-labeled GLUT1
and GLUT4 sequences were resolved by high-ionic-strength polyacrylamide gel
electrophoresis (PAGE) (2).
Analysis of Hel-N1 expression in transfected 3T3-L1 cells. RNA, DNA, and
protein were isolated from cultured 3T3-L1 cells by using TriReagent (Molecular
Research Center, Inc.) as instructed by the manufacturer.
(i) DNA. Two hundred nanograms of cellular DNA was used as the template
for PCR performed with primers complementary to sequences in the 5￿ and 3￿
termini of the protein coding region of the Hel-N1 insert in the pBC expression
vector (sequences below). PCR products were resolved on a 1% agarose gel and
detected with ethidium bromide.
(ii) RNA. Five micrograms of total cellular RNA was used for reverse tran-
scription (RT) followed by PCR (RT-PCR) as described previously (18), using
random hexamers to prime the RT reaction. The RT products were then used for
two rounds of PCR amplification using nested oligonucleotide primers spanning
the region between the N-terminal T7 phage g10 epitope tag and the end of the
coding region. The outer set of primers consisted of the following: forward
primer (G10, complementary to the T7 phage g10 epitope tag), 5￿ CATATGG
CTAGCATGACT 3￿; and reverse primer (HE/AS11, complementary to the end
of coding of Hel-N1), 5￿ GGGGGAATTCCTAGGCTTTGTGCGTTTTG 3￿.
The inner set of nested primers consisted of the following: forward primer
(HE/AS12, complementary to the start of coding of Hel-N1), 5￿ GCGCCGCC
ATGGAAACACAAGTGTC 3￿; and reverse primer (HE/AS29, complementary
to the end of the coding region of Hel-N1 overlapping HE/AS11), 5￿ TAGTC
GAATTCGGCTTTGTGCGTTTTGTT 3￿. Reaction conditions were identical
for both set of primers: 30 cycles of 94￿C for 1 min, 50￿C for 1 min, and 72￿C for
2 min. One-fourth (5 ￿l) of the RT reaction product was used as the template for
the first round of PCR. Three microliters of the product of the second round of
PCR was resolved on a 1% agarose gel and detected by ethidium bromide. All
RNAs were transcribed in the presence and absence of reverse transcriptase to
detect any possible contamination by DNA.
(iii) Protein. Proteins were separated by sodium dodecyl sulfate (SDS)-PAGE
(10% gel) and electrotransferred to a Hybond-ECL nitrocellulose membrane
(Amersham). The membranes were processed as instructed by the manufacturer,
and the proteins were detected by enhanced chemiluminescence. When compar-
isons between control and transfected cell lines were made, the analysis was
performed on separate gels on the same apparatus at the same time. The
individual blots generated were probed simultaneously.
Polysome profiles: analysis of polysomes by sucrose density gradients. Poly-
some profiles were generated as described by Long and Pekala (28). Briefly,
three 10-cm-diameter plates of 3T3-L1 adipocytes were used for each polysome
distribution analysis. Cells were washed twice with ice-cold phosphate-buffered
saline containing 100 ￿g of cycloheximide per ml and lysed by the addition of 200
￿l of polysome lysis buffer (100 mM KCl, 5 mMMgCl2, 10 mMHEPES [pH 7.4],
100 ￿g of cycloheximide per ml, 0.5% Nonidet P-40). The lysate was transferred
to a 1.5-ml microcentrifuge tube and passaged three to four times through a
27-gauge needle to ensure cell lysis. Nuclei were pelleted by centrifugation at 4￿C
and 12,000 ￿ g for 5 min. The supernatant was then subjected to centrifugation
one more time to ensure the removal of any nuclei. The resulting supernatant
was layered on a linear 15 to 45% (wt/vol) sucrose gradient in polysome gradient
buffer (100 mMKCl, 5 mMMgCl2, 10 mMHEPES [pH 7.4]), and gradients were
centrifuged at 35,000 rpm for 2 h at 4￿C in a Beckman SW41 rotor. Gradient
fractions were collected with a Brandel model 184 density gradient fractionator.
RNA was purified from the sucrose gradient fractions by proteinase K digestion
followed by phenol extraction. Each sample was diluted with an equal volume of
a proteinase K solution (0.2 M Tris-Cl [pH 7.5], 25 mM EDTA, 0.3 M NaCl, 2%
SDS, and 250 ￿g of proteinase K per ml). Samples were incubated at 45￿C for 30
min and then extracted first with phenol-chloroform and then with chloroform
alone. The aqueous phase was recovered, and the RNA was precipitated with 0.3
M sodium acetate (pH 5.2) and 2.5 volumes of ethanol. GLUT1 mRNA was
analyzed by RNase protection assay.
RNase protection assay. The RNase protection assay was performed by using
an RPA II assay kit (Ambion, Austin, Tex.) as instructed by the manufacturer.
The GLUT1 RNase protection assay probe contains the HincII-HindIII frag-
ment of the GLUT1 coding region. The total probe size is approximately 290
bases. The protected fragment is 257 bp.
Triglyceride assay. The triglyceride assay was performed with a triglyceride kit
(Sigma Diagnostics, St. Louis, Mo.). Consistent with other experiments per-
formed in these studies, two 10-cm-diameter plates were harvested on day 8 of
the differentiation program.
Nucleotide sequence accession numbers. The cDNA sequences of GLUT1 and
GLUT4 are deposited in GenBank under accession numbers M23384 and
M23383, respectively.
RESULTS
Characterization of stable 3T3-L1 transfectants expressing
Hel-N1. Stable transfectants expressing Hel-N1 were prepared
by the calcium phosphate precipitation method. After selec-
tion, based on G418 resistance, clones were combined, pas-
saged twice, and replated, and differentiation relative to that of
untransfected 3T3-L1 cells was monitored (Fig. 1). Quantifi-
cation of triacylglycerol content on day 8 after induction of
differentiation demonstrated that the Hel-N1 transfectants ac-
cumulated 40% more lipid than controls: 0.160 ￿ 0.002
(mean ￿ standard deviation [SD]) and 0.220 ￿ 0.005 ￿mol of
triacylglycerol/106 cells for untransfected and Hel-N1-trans-
fected cells, respectively. This difference is significant by Stu-
VOL. 17, 1997 REGULATION OF GLUT1 GENE EXPRESSION BY Hel-N1 955
FIG. 1. Effect of expression of rHel-N1 on 3T3-L1 adipocyte conversion. (A) Macroscopic appearance of oil red O-stained two-well chamber slides on which cells
were induced to differentiate. Inductions were performed in duplicate (wells 1 and 2) for each time point for both cell lines, and the slides were fixed on days 5, 9, and
14 following exposure to inducing agents. No difference between untransfected and Hel-N1-transfected cells was discernible on day 1. (B) Microscopic appearance of
cells on the slides in panel A. Representative areas at low power of untransfected cells (a to c) and Hel-N1 transfectants (d to f) are shown on days 5 (a and d) 9 (b,
and e), and 14 (c and f) following induction.
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dent’s t test (P ￿ 0.05). Morphologically, there appeared to be
a more rapid onset of the adipocyte phenotype, which will be
examined in greater detail in future studies. As shown in Fig.
1, a uniform distribution of the cells exhibiting the adipocyte
phenotype among the pooled clones was observed. In contrast,
3T3-L1 cells transfected with other expression constructs fol-
lowed by selection using G418 gave rise to a clonal rather than
uniform differentiation (19).
Verification of the presence of the Hel-N1 DNA, RNA, and
protein in the stable transfectants. The presence of the recom-
binant Hel-N1 (rHel-N1) DNA and RNA in the Hel-N1 trans-
fectants and its absence from untransfected 3T3-L1 genomic
DNA was confirmed by PCR and RT-PCR amplification, re-
spectively. As shown in Fig. 2, specific primers were used to
amplify the protein coding region of rHel-N1 cDNA. The data
demonstrate the presence of rHel-N1 sequences in DNA iso-
lated from Hel-N1-transfected 3T3-L1 cells (Fig. 2B, lanes 4
and 8) and its absence in the untransfected 3T3-L1 cells (lanes
3 and 7). In addition, the presence of the Hel-N1 mRNA was
detected by RT-PCR as described in Materials and Methods
(Fig. 2C). Primers complementary to a sequence within the
N-terminal g10 epitope tag of the recombinant plasmid ex-
cluded the possibility of amplification of an endogenous mu-
rine homolog of Hel-N1.
The presence of the Hel-N1 protein was detected by immu-
noblotting of cell extracts prepared from transfected and un-
transfected cells with rabbit polyclonal antiserum to rHel-N1
(14). As shown in Fig. 2D (lane 3), a protein of approximately
38 kDa, consistent with the size of epitope-tagged Hel-N1, was
detected in the transfected cells at confluence, and no change
in the level of expressed Hel-N1 protein was observed in fully
differentiated adipocytes. Small amounts of cross-reactive pro-
teins were also detected in the transfected and untransfected
adipocytes (lanes 2 and 3).
Following verification of the presence of the Hel-N1 DNA,
RNA, and expressed protein in the stable transfectants, studies
were undertaken to determine the effect of Hel-N1 transfec-
tion on the expression of the glucose transporters which are
characteristic of adipocyte cells.
Expression of GLUT1 and GLUT4 in the stable transfec-
tants. Cell extracts were prepared as detailed in Materials and
Methods, and protein from 106 cells was separated by SDS-
PAGE and analyzed by immunoblotting. Extracts from cells
were collected over a period from confluence (day -2) to fully
differentiated (day 10 to 15). As a point of reference, these
preadipocytes are considered 2 days postconfluent on day 0,
when their differentiation program is accelerated by exposure
to MIX, DEX, and insulin (see Materials and Methods). Blots
were analyzed by using specific polyclonal antisera against
GLUT1 and GLUT4 (Fig. 3). As shown in Fig. 3A, we ob-
served in the Hel-N1 transfectants a major (8- to 10-fold)
increase in the expression of the GLUT1 protein which corre-
lated with the onset of the adipocyte phenotype. This increase
FIG. 2. Expression of Hel-N1 in transfected preadipocytes. (A) Schematic
diagram of Hel-N1 protein and the cDNA inserted into the pBC expression
vector. The locations of the primers used for PCR amplification are indicated
(see Materials and Methods for primer sequences). (B) PCR analysis of genomic
DNA isolated from untransfected and Hel-N1-transfected 3T3-L1 cells, using the
two sets of primers diagrammed in panel A. Templates: lanes 1 and 5 (￿), no
template; lanes 2 and 6 (￿), 1 fg of plasmid pBC-Hel-N1 used for transfection;
lanes 3 and 7 (L1), 0.2 ￿g of genomic DNA from untransfected 3T3-L1 cells;
lanes 4 and 8 (H1), 0.2 ￿g of genomic DNA from Hel-N1-transfected cells.
Primers: lanes 1 to 4, HE/SE12 and HE/AS11; lanes 5 to 8, G10 (complementary
to 18 nt of an N-terminal epitope tag expressed by the construct used to transfect
3T3-L1 cells) and HE/AS11. Lane 9, ￿X174/HaeIII marker. (C) RT-PCR anal-
ysis of total cellular RNA isolated from untransfected cells and Hel-N1 trans-
fectants. Templates: Lane 2, none, lane 3, Hel-N1 plasmid (1 pg); lanes 4 to 7,
RNA (5 ￿g), reverse transcribed and amplified by two rounds of nested PCR;
lanes 4 and 6, untransfected samples prepared by using no reverse transcriptase;
lanes 5 and 7, reverse transcriptase present. (D) Immunoblot of Hel-N1 protein
in extracts prepared from untransfected 3T3-L1 cells and 3T3-L1 cells trans-
fected with Hel-N1. Protein the size of Hel-N1 was detected in cells transfected
with the Hel-N1 construct, using rabbit polyclonal antiserum to recombinant
Hel-N1. A minor amount of cross-reactive protein of approximately the same
size was detected in untransfected cells. Lanes: 1, rHel-N1 protein marker (5 ng);
lane 2, protein (200 ￿g) isolated from untransfected 3T3-L1 cells at confluence;
lane 3, protein (200 ￿g) isolated from Hel-N1 transfected cells at confluence.
FIG. 3. Expression of glucose transporters GLUT1 and GLUT4. Shown are
Western blots of cell extracts prepared from both untransfected 3T3-L1 cells and
the Hel-N1 transfectants throughout the differentiation time course. Total cell
extracts were prepared at each time point, and protein equivalent to 106 cells was
analyzed by SDS-PAGE and immunoblotting. Blots were generated and probed
with antibodies specific to GLUT1 (A) and GLUT4 (B). The data shown are
representative of an experiment performed twice with each of two independent
sets of transfected cells. Protein bands were quantified with Imagequant software
(Molecular Dynamics, Sunnyvale, Calif.). CTL, control.
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in GLUT1 expression did not occur in the absence of the
hormone induction. To verify that the detected antigen was
indeed all GLUT1, the same blot was stripped and reprobed
with antiserum from which the GLUT1 antibody had been
preabsorbed by using an antigen affinity column. Use of this
antibody preparation resulted in a loss of detection of the
antigen, confirming that the accumulated protein was GLUT1
(data not shown). The bands of various sizes observed in the
Western blot analysis were believed to represent variations in
the glycosylation state of the GLUT1 protein (30). We also
noted that the expression pattern of GLUT1 in the 3T3-L1
cells during days 0 through 5 reflects a normal decrease in
GLUT1 content, consistent with the cells being at confluence
for several days prior to induction of differentiation (47).
For comparison, expression of the differentiation-specific
glucose transporter, GLUT4, was not affected by expression of
Hel-N1 (Fig. 3B). In parallel experiments, stable transfectants
obtained by using truncated fragments of Hel-N1 (Hel-N2 and
RRM3 [27]) did not exhibit a large increase in GLUT1 protein
accumulation over the differentiation time course (data not
shown).
In vitro binding of Hel-N1 to sequences in the 3￿UTR of
GLUT1 mRNA. RNA gel shift assays and immunoprecipitation
experiments were performed to determine whether rHel-N1
could bind to the 3￿UTR of GLUT1 mRNA. Sequences within
the 887-base 3￿UTR were amplified as five contiguous frag-
ments by PCR using forward primers containing the T7 RNA
polymerase promoter (Fig. 4A). Radiolabeled transcripts were
prepared from the full-length 3￿UTR as well as the fragments
of the 3￿UTR, and gel shifts and immunoprecipitations were
performed as described in Materials and Methods. The results
(Fig. 4B, lane 12; Fig. 5A, lane 12) demonstrate the binding of
rHel-N1 to the ￿1 region (nt 1820 to 1950), which, as shown in
Table 1, consists of a 68.5% A￿U region, with specific subre-
gions reaching as high as 73% A￿U. No binding to the other
four fragments of the GLUT1 3￿UTR, which range from 37.5
to 69% A￿U, was observed. The overall A￿U content of the
GLUT1 3￿UTR is 49.3%. The results of binding of rHel-N1 to
the other GLUT1 transcripts and their characteristics are sum-
marized in Table 1. Hel-N1 bound to the full-length 3￿UTR
(Fig. 5A, lane 1), but less full-length RNA than ￿1 RNA was
immunoprecipitated on a molar basis (Fig. 4B, lane 7). The
mobility of the full-length transcript shifted in the presence of
rHel-N1 (Fig. 5A, lane 2) but because of the large size of this
transcript (887 nt), it is difficult to compare it quantitatively
with that of the ￿1 fragment. Recent experiments have further
defined the binding site to a U-rich loop between positions
1911 and 1950 of GenBank sequence M23384, within the ￿1
construct. Various attempts to directly immunoprecipitate en-
dogenous or exogenous Hel-N1 family proteins from whole cell
extracts and to identify in vivo bound RNAs have not suc-
ceeded presumably because the epitopes on the endogenous
proteins are not accessible in whole cell extracts.
As shown above, 3T3-L1 adipocytes express the insulin-re-
sponsive glucose transporter GLUT4, but its expression is not
altered in Hel-N1-transfected cells. Radiolabeled probes for
immunoprecipitation and gel shift assays were prepared from
truncated portions of the 3￿UTR of GLUT4 by restriction
enzyme digestion as described in Materials and Methods. The
overall A￿U content of the GLUT4 3￿UTR is 46.5%, while
the HindIII truncation contains 43.5% A￿U and the TfiI trun-
cated transcript contains 41% A￿U. The region that is most
AU rich (55.5%) lies between the HindIII site and the end of
the full-length GLUT4 3￿UTR transcript (Table 1). The results
of determinations of binding to these regions (Fig. 5B, lanes 1
to 6, and data not shown) demonstrate that Hel-N1 is not a
ligand for the GLUT4 3￿UTR, consistent with its showing no
effect on GLUT4 expression in the differentiating Hel-N1
transfectants (Fig. 3B).
Analysis of GLUT1 mRNA levels during a differentiation
time course. RNA from the untransfected cells and the stable
transfectants was isolated at several time points in their differ-
entiation time course as described in Materials and Methods.
Upon Northern blot analysis of the RNA from the time course,
FIG. 4. Binding of Hel-N1 in vitro to sequences in the 3￿UTR of GLUT1
mRNA. (A) Diagram of GLUT1 mRNA showing regions tested for binding to
rHel-N1 protein. (B) Immunoprecipitation of rHel-N1 bound to radiolabeled
transcripts of full-length GLUT1 3￿UTR and segments within the 3￿UTR, each
represented by ￿. Lanes 1 to 6, 32P-labeled transcripts remaining in the super-
natants after the first step of binding; lanes 7 to 12, RNA bound to Hel-N1 after
five washes.
FIG. 5. Mobility shift assay of rHel-N1 binding in vitro to GLUT1 and
GLUT4 transcripts. (A) RNA gel mobility assay of the GLUT1 transcripts
diagrammed in Fig. 4A. Lanes 1, 3, 5, 7, 9, and 11, RNA only; lanes 2, 4, 6, 8, 10,
and 12, RNA plus 0.5 ￿g of rHel-N1. (B) Gel retardation experiments using
Hel-N1 and 32P-labeled transcripts of GLUT4 3￿UTR truncated at the indicated
restriction enzyme sites is compared to binding (￿1) and nonbinding (￿3) se-
quences from the 3￿UTR of GLUT1. Lanes 1, 3, 5, 7, and 9, RNA only; lanes 2,
4, 6, 8, and 10, RNA plus 0.5 ￿g of rHel-N1. The GLUT4 transcripts are 999 nt
(full-length 3￿UTR plus 3￿ end of coding and polylinker cut at XhoI), 800 nt
(HindIII truncation), and 316 nt (TfiI).
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an approximate 2-fold (1.8￿ 0.15-fold) increase in the amount
of GLUT1 mRNA was observed after days 4, 5, and 8 in the
Hel-N1 transfectants in comparison to the untransfected cells
(Fig. 6A). These results are consistent with the possibility that
the increase in GLUT1 protein following transfection with
Hel-N1 involves stabilization of the GLUT1 mRNA. Exami-
nation of the half-life of the GLUT1 message in untransfected
and Hel-N1-expressing cells, using actinomycin D to inhibit
transcription, is shown in Fig. 6B and C. In cells expressing
Hel-N1, the GLUT1 message was markedly stabilized, exhib-
iting a half-life of 7.0￿ 0.5 h (mean￿ SD, n￿ 3). The half-life
of GLUT1 mRNA in the untransfected cells was determined to
be 4.8 ￿ 0.3 h (mean ￿ SD, n ￿ 3), which compares favorably
to the 4.5 ￿ 1.7 h reported by Kaestner et al. (21). These data
suggest that the accumulation of GLUT1 protein results from
increased levels of GLUT1 mRNA, which corresponds with a
significant stabilization of the message.
Functional assay of increased GLUT1 expression. The in-
creased GLUT1 protein detected in the immunoblot analysis
was confirmed by a functional assay of 2-deoxyglucose uptake.
The Hel-N1 transfectants exhibited a threefold increase in the
rate of glucose uptake compared to the wild-type cells (153 ￿
10 pmol/min/106 cells for untransfected cells; 518 ￿ 73 pmol/
min/106 cells for Hel-N1 transfectants). To determine whether
this increased rate of glucose uptake could be attributed to the
overexpression of GLUT1 in the stable transfectants, mem-
brane fractionation was performed on day 8 untransfected and
Hel-N1 transfected cells. Comparison of GLUT1 protein con-
tent in isolated total cellular membranes indicated an 8.3 ￿
0.9-fold overexpression of the GLUT1 protein in the Hel-N1
transfectants. The sublocalization of the GLUT1 protein was
further investigated, as shown in a representative immunoblot
prepared by using isolated plasma and microsomal membrane
fractions (Fig. 7). Purification of the plasma membranes (ap-
proximately 28-fold purification with a 6.5% yield) and micro-
somal membranes (approximately 60-fold purification with a
10% yield) demonstrated a 3-fold increase in the GLUT1 pro-
tein content associated with the plasma membrane fraction
relative to untransfected cells, consistent with the increased
rate of 2-deoxyglucose uptake described above. The microso-
mal GLUT1 protein content in the transfectants increased
4.8 ￿ 0.8-fold, suggesting that a substantial portion of the
GLUT1 antigen detected in the immunoblots represented pro-
tein in various stages of processing or sequestration.
GLUT1 mRNA distribution in polysome profiles following
Hel-N1 transfection. Sucrose density gradient analysis was per-
formed to determine if expression of Hel-N1 altered the dis-
tribution of GLUT1 mRNA among ribosomes and polysomes,
thereby potentially affecting the rate of translation or half-life
of the message. The analysis was performed on day 8 following
induction of differentiation, and representative polysome pro-
files for untransfected 3T3-L1 cells (Fig. 8A) and Hel-N1
transfectants (Fig. 8B) are shown. A shift in the profile was
observed in the Hel-N1-transfected cells in which GLUT1
mRNA was absent from fraction 4 (40S preinitiation complex)
and fractions 5 to 6 (80S initiation complex). In comparison of
several independent gradients, the GLUT1 mRNA distribu-
tion was consistently skewed toward the densest portion of the
gradient, which contained polysomes with increasing numbers
of ribosomes (fractions 10 to 16). While the bulk of the
GLUT1 mRNA is localized to fractions 13 to 15 in both gra-
dients (shaded portion in polysome profile), these fractions
TABLE 1. Comparison of sequences ￿1 to ￿5 within the 3￿UTR of GLUT1 mRNA and the region of greatest A/U richness
within the 3￿UTR of GLUT4
a All sequences are listed 5￿ to 3￿.
b Transcripts of the 5￿-most 102 nt (51% A￿U) and the 3￿-most 40 nt (73% A￿U) are individually bound by Hel-N1, with the greatest binding
to the shorter, more A/U-rich 3￿ end of the ￿1 sequence.
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represented heavier polysomes which shifted into the smaller
peak at the very bottom of the gradient in the Hel-N1 trans-
fectants (Fig. 8B). The loss of detection of GLUT1 mRNA in
the less dense fractions (fractions 4 to 6) of the gradient is
consistent with an up-regulated loading of ribosomes onto
GLUT1 mRNA in the cells expressing Hel-N1, indicating an
acceleration in the initiation of translation.
DISCUSSION
Initial attempts to create stable transfectants which ex-
pressed Hel-N1 in various mammalian cell lines were pre-
cluded due to cell death or cytostasis. In this study, we suc-
cessfully expressed Hel-N1 in 3T3-L1 preadipocytes. These
cells, subcloned from mouse embryo fibroblasts, differentiate
in monolayer culture into cells exhibiting the biochemical and
morphological characteristics of adipocytes (9, 29). With the
characterization of the 3T3-L1 system over the last two de-
cades, adipocyte differentiation has emerged as a model for
studies of gene expression and terminal cell differentiation (9,
29). The combination of the 3T3-L1 cell line and successful
expression of various forms of Hel-N1 permitted an approach
to the functional analysis of this highly specialized RRM-con-
taining protein.
GLUT1, a ubiquitously expressed glucose transporter, is a
member of a multigene transporter family (33). In the 3T3-L1
fibroblasts, GLUT1 mRNA exhibits a half-life of 42 ￿ 9 min
and behaves much like an immediate-early mRNA (8). How-
ever, as the cells differentiate and express the adipose pheno-
type, a marked stabilization of the half-life occurs increasing to
4.5 ￿ 1.7 h (21). This is particularly interesting in that quan-
tifiable GLUT1 mRNA and protein content remain at or be-
low the levels found in the undifferentiated cells, suggesting
that a transcriptional down-regulation must compensate for
the increased stability (42, 43). In the Hel-N1 transfectants, we
have observed an increased accumulation of the GLUT1
mRNA, due in part to a further stabilization of the message
(half-life of 7.0 ￿ 0.5 h), which then translates into an in-
creased GLUT1 protein content. While both Hel-N1 and
GLUT1 proteins are expressed in the uninduced transfected
fibroblasts, the observed 8- to 10-fold increase in GLUT1 pro-
tein occurs only as the cells attain the adipocyte phenotype and
only in the hormonally induced transfectants. This finding sug-
gests that essential adipose-specific regulatory factors or pro-
teins expressed as the cells differentiate are required to pro-
mote the Hel-N1-induced alteration of GLUT1 expression.
With respect to the function of GLUT1, this regulation ap-
pears to signal an increased need for glucose during the dif-
ferentiation process.
Use of RNA gel shift analysis and immunoprecipitation
techniques demonstrated that in vitro, Hel-N1 bound specifi-
cally to a 130-nt AU-rich region of the GLUT1 3￿UTR which
we refer to as ￿1. It is interesting that the binding domain is
within a 40-nt region (nt 1891 to 1930) which exhibits 100%
homology between the human and murine GLUT1 mRNAs,
suggesting functional importance through phylogenetic conser-
vation.
While an 8- to 10-fold increase in GLUT1 protein was ob-
served in the Hel-N1 transfectants, examination of the distri-
bution of the protein indicated that only a 3-fold increase
occurred at the plasma membrane. This corresponded well to
the threefold increase in rates of basal glucose transport. It has
been reported that transporters detected in association with
the plasma membrane are largely active (47). However, West-
ern blotting will also detect transport-inactive intermediates in
normal transporter trafficking housed in plasma membrane-
associated but occluded vesicles. These intermediates have
FIG. 6. Effect of Hel-N1 expression on GLUT1 mRNA accumulation and
turnover. (A) Northern blot of RNA isolated from untransfected cells and stable
transfectants on days 4, 5, and 8 of the differentiation time course. RNAs (20
￿g/lane) were subjected to electrophoresis and analyzed as described in Mate-
rials and Methods. Blots were sequentially hybridized with cDNA probes corre-
sponding to GLUT1 and ￿-actin. (B) On day 8 of a differentiation time course,
the wild-type and Hel-N1-transfected cells were treated with actinomycin D
(time zero), RNA was isolated at the indicated time points, and Northern blot
analysis was performed for GLUT1 as described in Materials and Methods. (C)
The hybridization patterns of six independent experiments were analyzed by
densitometric scanning, quantified with Imagequant software (Molecular Dy-
namics), and plotted as mean percent mRNAs remaining in the untransfected
3T3-L1 cells (■) and Hel-N1 transfectants (F). The GLUT1 mRNA half-lives
within experimental variation were calculated according to linear regression
values to be 4.8 ￿ 0.7 h in 3T3-L1 and 7.0 ￿ 0.5 h in the Hel-N1 transfectants.
The slopes of the two lines displayed were determined to be significantly different
with P ￿ 0.0001.
FIG. 7. Membrane distribution of GLUT1 protein in untransfected and
Hel-N1 transfectants. Plasma membranes (PM) and microsomal membranes
(MM) were isolated on day 8 of a differentiation time course from untransfected
3T3-L1 cells (lanes 1 and 3) and Hel-N1-transfected cells (lanes 2 and 4). The
isolated membranes were subjected to immunoblot analysis as described in
Materials and Methods. Densitometric quantification (Imagequant software;
Molecular Dynamics) of the GLUT1 protein content associated with the plasma
membrane and microsomal membrane fractions of Hel-N1 transfectants relative
to untransfected cells demonstrated 3- and 4.8-fold increases, respectively.
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been suggested to contribute to a relatively small degree to
total plasma membrane GLUT1 (47). The bulk of the in-
creased GLUT1 appears to have been localized to the intra-
cellular pool of transporters, similar to the finding of Yang et
al. (47) that the decrease in the intrinsic activity of the GLUT1
transporter with respect to differentiation appeared to be due
to transporter sequestration within the cell. These observations
suggest that ectopic expression of Hel-N1, while altering the
expression of GLUT1, did not alter the normal equilibrium
distribution of the transporter. Moreover, we suggest that it is
the overexpression of GLUT1 at the plasma membrane which
leads to the increased basal rate of transport, resulting in a
40% increase in stored triacylglycerol.
Detection of the broad GLUT1 band by Western analysis
was inhibited by adsorption of the anti-GLUT1 antibody to an
antigen affinity column. While confirming that the signal was
generated by GLUT1 protein, this did not explain the apparent
multiple forms observed. Differences in electrophoretic mobil-
ity on SDS-PAGE of immunoreactive GLUT1 have been dem-
onstrated to arise from differences in the complexity of N-
linked carbohydrate groups (26). Glycosylation of the GLUT1
transporter can be modulated by cytokines, growth factors such
as transforming growth factor ￿1, and glucose deprivation,
leading to the detection of multiple bands and/or broad bands
(31, 34). The heterogeneity of glycosylation has been suggested
to have a functional role in regulating glucose transporter
kinetic activity or differential subcellular localization (26). In
these situations, molecular size has been reported in the range
from ￿47 to 65 kDa (26, 31, 34). Thus, we suggest that alter-
ations in the complexity of glycosylation of GLUT1 protein in
the presence of Hel-N1 resulted in the broad, multiple-com-
ponent band detected in our studies.
Polysome profile analysis demonstrated a Hel-N1-associated
effect on translation. This technique permitted analysis of the
association of the GLUT1 mRNA with the ribosomal subunits
and polysomes, in both untransfected and Hel-N1-transfected
3T3-L1 adipocytes. The location of GLUT1 mRNA in the
polysome profiles demonstrates a marked acceleration of the
progression from the preinitiation complex to polysomes in the
Hel-N1 transfectants, which suggests an enhancement of initi-
ation. In addition, the bulk of the GLUT1 mRNA was associ-
ated with heavier (more dense) polysomes, consistent with an
increased efficiency of ribosome loading and translation of this
message. This interpretation is supported by studies on the
translational regulation of tra-2, in which deletion of a negative
control region from the 3￿UTR led to an increased rate of
translation coincident with movement of the message to the
heavy (more dense) polysomes (17). This effect on the initia-
tion of protein synthesis may result in both the stabilization of
the GLUT1 mRNA and the increased synthesis of GLUT1
protein. These data suggest that control of translation, at the
level of initiation, may be a major function of the Hel-N1
protein. However, the differentiation-specific requirement for
Hel-N1-enhanced GLUT1 expression implies involvement of
regulatory events other than just binding of Hel-N1 to the ￿1
region of the GLUT1 3￿UTR.
While our studies have been conducted with adipocytes, it is
important to note that Hel-N1 was originally cloned from a
fetal human brain cDNA library and found to be highly ho-
mologous to the D. melanogaster neuronal protein ELAV,
which functions in differentiation (27). In addition, examina-
tion of several human brain tumor cell lines by immunoblot
analysis indicated the presence of high levels of endogenous
human ELAV proteins (14). Interestingly, GLUT1 is ex-
pressed at high levels in neuronal tissues, the blood-brain bar-
rier, and the brain (30). The coexistence of Hel-N1 and
GLUT1 mRNAs in the brain suggests that these molecules
may interact in vivo and that Hel-N1 may function in neuronal
differentiation as it does in adipogenesis.
The differentiation-dependent overexpression of GLUT1,
potentially resulting from a direct interaction of Hel-N1 with
the 3￿UTR of its mRNA, is consistent with the increased met-
abolic needs of the transfected cell as it begins to synthesize
and store lipid at an enhanced rate. Although the precise
mechanism of its effects on cell growth and protein expression
FIG. 8. Polysome profiles and GLUT1 localization. (A) A postmitochondrial
supernatant was prepared from untransfected cells on day 8 of a differentiation
time course and applied to a 15 to 45% sucrose density gradient, which was
centrifuged at 20,000 ￿ g for 2 h. The gradients were fractionated, and the
absorbance at 254 nm was measured, generating a polysome profile. The tops of
the gradients are to the left. RNA from the fractions was isolated, and GLUT1
content was determined by RNase protection assay. (B) Identical analysis for
Hel-N1 transfectants.
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will require further study, our data provide support for a role for
Hel-N1 in translational efficiency as well as message stability.
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